FDA Inspection 1158863 — Amarex Clinical Research, LLC
The FDA completed an inspection of Amarex Clinical Research, LLC on November 3, 2021 in Germantown, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 3, 2021
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Germantown, MD (United States)
Additional Details
Sponsor, Contract Research Organization